sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Mesalazine Market Insights, Forecast to 2025

Global Mesalazine Market Insights, Forecast to 2025

Category : Pharmaceuticals and Healthcare QY Research Pages :152
Published Date : 2019-10-22

 

Mesalazine, also known as mesalazine or 5-aminosalicylic acid (5-asa), is an anti-inflammatory drug used to treat inflammatory bowel diseases (including ulcerative colitis and crohn's disease).It is commonly used in mild to moderate severe diseases and is very effective in treating and maintaining relief from ulcerative colitis, which can be ingested through the mouth or rectum.It is structurally related to salicylate and non-steroidal anti-inflammatory drugs (such as acetyl salicylic acid) and has activity in inflammatory bowel disease.It is considered to be the active part of salazopyridine. The global Mesalazine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mesalazine market based on company, product type, end user and key regions. This report studies the global market size of Mesalazine in key regions like North America, Europe, China and Japan, focuses on the consumption of Mesalazine in these regions. This research report categorizes the global Mesalazine market by top players/brands, region, type and end user. This report also studies the global Mesalazine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: AstraZeneca Cosmo Pharmaceuticals Teva Mylan Sandoz Mesalamine Allergan Salix Pharmaceuticals Nogra Pharma Abbvie Takeda Janssen (Johnson & Johnson) Pfizer Ferring Boehringer Ingelheim Chiesi Farmaceutici Tillotts Pharma Dr Falk Pharma Cipla Synmosa Biopharma Corporation Lunan Better Pharmaceutical Shanghai Sine Promod Pharmaceutical Mesalazine market size by Type Oral Intake Rectum Intake Mesalazine market size by Applications Ulcerative Colitis Crohn's Disease Other Market size by Region North America United States Canada Mexico Europe Germany France UK Italy Russia Asia-Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines Vietnam Central & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa The study objectives of this report are: To study and analyze the global Mesalazine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Mesalazine market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Mesalazine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Mesalazine submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Mesalazine are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (KG). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mesalazine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Mesalazine Product Introduction 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Mesalazine Market Size Growth Rate by Type 1.4.2 Oral Intake 1.4.3 Rectum Intake 1.5 Market by Application 1.5.1 Global Mesalazine Market Size Growth Rate by Application 1.5.2 Ulcerative Colitis 1.5.3 Crohn's Disease 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Mesalazine Market Size 2.1.1 Global Mesalazine Revenue 2014-2025 2.1.2 Global Mesalazine Sales 2014-2025 2.2 Mesalazine Growth Rate by Regions 2.2.1 Global Mesalazine Sales by Regions 2.2.2 Global Mesalazine Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Mesalazine Sales by Manufacturers 3.1.1 Mesalazine Sales by Manufacturers 3.1.2 Mesalazine Sales Market Share by Manufacturers 3.2 Mesalazine Revenue by Manufacturers 3.2.1 Mesalazine Revenue by Manufacturers (2014-2019) 3.2.2 Mesalazine Revenue Share by Manufacturers (2014-2019) 3.3 Mesalazine Price by Manufacturers 3.4 Mesalazine Manufacturing Base Distribution, Product Types 3.4.1 Mesalazine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Mesalazine Product Type 3.4.3 Date of International Manufacturers Enter into Mesalazine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Mesalazine Sales by Type 4.2 Global Mesalazine Revenue by Type 4.3 Mesalazine Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Mesalazine Breakdown Data by Application 6 North America 6.1 North America Mesalazine by Country 6.1.1 North America Mesalazine Sales by Country 6.1.2 North America Mesalazine Revenue by Country 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Mesalazine by Type 6.3 North America Mesalazine by Application 7 Europe 7.1 Europe Mesalazine by Country 7.1.1 Europe Mesalazine Sales by Country 7.1.2 Europe Mesalazine Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Mesalazine by Type 7.3 Europe Mesalazine by Application 8 Asia Pacific 8.1 Asia Pacific Mesalazine by Region 8.1.1 Asia Pacific Mesalazine Sales by Region 8.1.2 Asia Pacific Mesalazine Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Thailand 8.1.10 Malaysia 8.1.11 Philippines 8.1.12 Vietnam 8.2 Asia Pacific Mesalazine by Type 8.3 Asia Pacific Mesalazine by Application 9 Central & South America 9.1 Central & South America Mesalazine by Country 9.1.1 Central & South America Mesalazine Sales by Country 9.1.2 Central & South America Mesalazine Revenue by Country 9.1.3 Brazil 9.2 Central & South America Mesalazine by Type 9.3 Central & South America Mesalazine by Application 10 Middle East and Africa 10.1 Middle East and Africa Mesalazine by Country 10.1.1 Middle East and Africa Mesalazine Sales by Country 10.1.2 Middle East and Africa Mesalazine Revenue by Country 10.1.3 Turkey 10.1.4 GCC Countries 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Mesalazine by Type 10.3 Middle East and Africa Mesalazine by Application 11 Company Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 Company Business Overview 11.1.3 AstraZeneca Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.1.4 AstraZeneca Mesalazine Products Offered 11.1.5 AstraZeneca Recent Development 11.2 Cosmo Pharmaceuticals 11.2.1 Cosmo Pharmaceuticals Company Details 11.2.2 Company Business Overview 11.2.3 Cosmo Pharmaceuticals Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Cosmo Pharmaceuticals Mesalazine Products Offered 11.2.5 Cosmo Pharmaceuticals Recent Development 11.3 Teva 11.3.1 Teva Company Details 11.3.2 Company Business Overview 11.3.3 Teva Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Teva Mesalazine Products Offered 11.3.5 Teva Recent Development 11.4 Mylan 11.4.1 Mylan Company Details 11.4.2 Company Business Overview 11.4.3 Mylan Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Mylan Mesalazine Products Offered 11.4.5 Mylan Recent Development 11.5 Sandoz Mesalamine 11.5.1 Sandoz Mesalamine Company Details 11.5.2 Company Business Overview 11.5.3 Sandoz Mesalamine Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Sandoz Mesalamine Mesalazine Products Offered 11.5.5 Sandoz Mesalamine Recent Development 11.6 Allergan 11.6.1 Allergan Company Details 11.6.2 Company Business Overview 11.6.3 Allergan Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Allergan Mesalazine Products Offered 11.6.5 Allergan Recent Development 11.7 Salix Pharmaceuticals 11.7.1 Salix Pharmaceuticals Company Details 11.7.2 Company Business Overview 11.7.3 Salix Pharmaceuticals Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Salix Pharmaceuticals Mesalazine Products Offered 11.7.5 Salix Pharmaceuticals Recent Development 11.8 Nogra Pharma 11.8.1 Nogra Pharma Company Details 11.8.2 Company Business Overview 11.8.3 Nogra Pharma Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Nogra Pharma Mesalazine Products Offered 11.8.5 Nogra Pharma Recent Development 11.9 Abbvie 11.9.1 Abbvie Company Details 11.9.2 Company Business Overview 11.9.3 Abbvie Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Abbvie Mesalazine Products Offered 11.9.5 Abbvie Recent Development 11.10 Takeda 11.10.1 Takeda Company Details 11.10.2 Company Business Overview 11.10.3 Takeda Mesalazine Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Takeda Mesalazine Products Offered 11.10.5 Takeda Recent Development 11.11 Janssen (Johnson & Johnson) 11.12 Pfizer 11.13 Ferring 11.14 Boehringer Ingelheim 11.15 Chiesi Farmaceutici 11.16 Tillotts Pharma 11.17 Dr Falk Pharma 11.18 Cipla 11.19 Synmosa Biopharma Corporation 11.20 Lunan Better Pharmaceutical 11.21 Shanghai Sine Promod Pharmaceutical 12 Future Forecast 12.1 Mesalazine Market Forecast by Regions 12.1.1 Global Mesalazine Sales Forecast by Regions 2019-2025 12.1.2 Global Mesalazine Revenue Forecast by Regions 2019-2025 12.2 Mesalazine Market Forecast by Type 12.2.1 Global Mesalazine Sales Forecast by Type 2019-2025 12.2.2 Global Mesalazine Revenue Forecast by Type 2019-2025 12.3 Mesalazine Market Forecast by Application 12.4 North America Mesalazine Forecast 12.5 Europe Mesalazine Forecast 12.6 Asia Pacific Mesalazine Forecast 12.7 Central & South America Mesalazine Forecast 12.8 Middle East and Africa Mesalazine Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Mesalazine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables and Figures Figure Mesalazine Product Picture Table Mesalazine Market Segments Table Key Manufacturers Mesalazine Covered Table Global Mesalazine Market Size Growth Rate by Type 2019-2025 (KG) & (Million US$) Figure Global Mesalazine Sales Market Share by Type in 2018 & 2025 Figure Oral Intake Product Picture Table Major Manufacturers of Oral Intake Figure Rectum Intake Product Picture Table Major Manufacturers of Rectum Intake Table Global Mesalazine Market Size Growth Rate by Application 2019-2025 (KG) Figure Global Mesalazine 4900 Sales Market Share by Application in 2018 Figure Ulcerative Colitis Figure Crohn's Disease Figure Other Figure Mesalazine Report Years Considered Figure Global Mesalazine Market Size 2014-2025 (Million US$) Figure Global Mesalazine Sales 2014-2025 (KG) Table Global Mesalazine Market Size by Regions 2014-2019 (KG) & (Million US$) Table Global Mesalazine Sales by Regions 2014-2019 (KG) Table Global Mesalazine Sales Market Share by Regions 2014-2019 Figure Global Mesalazine Sales Market Share by Regions 2014-2019 Figure 2018 Global Mesalazine Sales Market Share by Regions Table Global Mesalazine Revenue by Regions 2014-2019 (Million US$) Table Global Mesalazine Revenue Market Share by Regions 2014-2019 Figure Global Mesalazine Revenue Market Share by Regions 2014-2019 Figure 2018 Global Mesalazine Revenue Market Share by Regions Table Global Mesalazine Sales by Manufacturers (2014-2019) (KG) Table Global Mesalazine Sales Share by Manufacturers (2014-2019) Figure Global Mesalazine Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Mesalazine Revenue by Manufacturers (2014-2019) (Million USD) Table Mesalazine Revenue Share by Manufacturers (2014-2019) Figure Mesalazine Value Share by Manufacturers in 2018 Table Key Manufacturers Mesalazine Price (2014-2019) (USD/KG) Table Mesalazine Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Mesalazine Product Type Table Date of International Manufacturers Enter into Mesalazine Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Mesalazine Sales by Type (2014-2019) (KG) Table Global Mesalazine Sales Share by Type (2014-2019) Figure Global Mesalazine Sales Market Share by Type (2014-2019) Figure Global Mesalazine Sales Market Share by Type in 2018 Table Global Mesalazine Revenue by Type (2014-2019) (Million US$) Table Global Mesalazine Revenue Share by Type (2014-2019) Figure Global Mesalazine Revenue Market Share by Type (2014-2019) Figure Global Mesalazine Revenue Market Share by Type in 2018 Table Mesalazine Price by Type 2014-2019 (USD/KG) Table Global Mesalazine Sales by Application (2014-2019) (KG) Table Global Mesalazine Sales Share by Application (2014-2019) Figure Global Sales Mesalazine Market Share by Application (2014-2019) Figure Global Sales Mesalazine Market Share by Application in 2018 Figure North America Mesalazine Sales Growth Rate 2014-2019 (KG) Figure North America Mesalazine Revenue Growth Rate 2014-2019 (Million US$) Table North America Mesalazine Sales by Country (2014-2019) (KG) Table North America Mesalazine Sales Market Share by Country (2014-2019) Figure 2018 North America Mesalazine Sales Market Share by Country Table North America Mesalazine Revenue by Country (2014-2019) (Million US$) Table North America Mesalazine Revenue Market Share by Country (2014-2019) Figure 2018 North America Mesalazine Revenue Market Share by Country Figure United States Mesalazine Sales Growth Rate (2014-2019) (KG) Figure United States Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Canada Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Canada Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Mexico Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Table North America Mesalazine Sales by Type (2014-2019) (KG) Table North America Mesalazine Sales Market Share by Type (2014-2019) Figure 2018 North America Mesalazine Market Share by Type Table North America Mesalazine Sales by Application (2014-2019) (KG) Table North America Mesalazine Sales Market Share by Application (2014-2019) Figure 2018 North America Mesalazine Market Share by Application Figure Europe Mesalazine Sales Growth Rate 2014-2019 (KG) Figure Europe Mesalazine Revenue Growth Rate 2014-2019 (Million US$) Table Europe Mesalazine Sales by Country (2014-2019) (KG) Table Europe Mesalazine Sales Market Share by Country (2014-2019) Figure 2018 Europe Mesalazine Sales Market Share by Country Table Europe Mesalazine Revenue by Country (2014-2019) (Million US$) Table Europe Mesalazine Revenue Market Share by Country (2014-2019) Figure 2018 Europe Mesalazine Revenue Market Share by Country Figure Germany Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Germany Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure France Mesalazine Sales Growth Rate (2014-2019) (KG) Figure France Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure UK Mesalazine Sales Growth Rate (2014-2019) (KG) Figure UK Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Italy Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Russia Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Table Europe Mesalazine Sales by Type (2014-2019) (KG) Table Europe Mesalazine Sales Market Share by Type (2014-2019) Figure 2018 Europe Mesalazine Market Share by Type Table Europe Mesalazine Sales by Application (2014-2019) (KG) Table Europe Mesalazine Sales Market Share by Application (2014-2019) Figure 2018 Europe Mesalazine Market Share by Application Figure Asia Pacific Mesalazine Sales Growth Rate 2014-2019 (KG) Figure Asia Pacific Mesalazine Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Mesalazine Sales by Region (2014-2019) (KG) Table Asia Pacific Mesalazine Sales Market Share by Region (2014-2019) Figure 2018 Asia Pacific Mesalazine Sales Market Share by Region Table Asia Pacific Mesalazine Revenue by Region (2014-2019) (Million US$) Table Asia Pacific Mesalazine Revenue Market Share by Region (2014-2019) Figure 2018 Asia Pacific Mesalazine Revenue Market Share by Country Figure China Mesalazine Sales Growth Rate (2014-2019) (KG) Figure China Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Japan Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure South Korea Mesalazine Sales Growth Rate (2014-2019) (KG) Figure South Korea Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure India Mesalazine Sales Growth Rate (2014-2019) (KG) Figure India Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Australia Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Indonesia Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Thailand Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Malaysia Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Philippines Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Vietnam Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Mesalazine Sales by Type (2014-2019) (KG) Table Asia Pacific Mesalazine Sales Market Share by Type (2014-2019) Figure 2018 Asia Pacific Mesalazine Market Share by Type Table Asia Pacific Mesalazine Sales by Application (2014-2019) (KG) Table Asia Pacific Mesalazine Sales Market Share by Application (2014-2019) Figure 2018 Asia Pacific Mesalazine Market Share by Application Figure Central & South America Mesalazine Sales Growth Rate 2014-2019 (KG) Figure Central & South America Mesalazine Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Mesalazine Sales by Country (2014-2019) (KG) Table Central & South America Mesalazine Sales Market Share by Country (2014-2019) Figure 2018 Central & South America Mesalazine Sales Market Share by Country Table Central & South America Mesalazine Revenue by Country (2014-2019) (Million US$) Table Central & South America Mesalazine Revenue Market Share by Country (2014-2019) Figure 2018 Central & South America Mesalazine Revenue Market Share by Country Figure Brazil Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Brazil Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Mesalazine Sales by Type (2014-2019) (KG) Table Central & South America Mesalazine Sales Market Share by Type (2014-2019) Figure 2018 Central & South America Mesalazine Market Share by Type Table Central & South America Mesalazine Sales by Application (2014-2019) (KG) Table Central & South America Mesalazine Sales Market Share by Application (2014-2019) Figure 2018 Central & South America Mesalazine Market Share by Application Figure Middle East and Africa Mesalazine Sales Growth Rate 2014-2019 (KG) Figure Middle East and Africa Mesalazine Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Mesalazine Sales by Country (2014-2019) (KG) Table Middle East and Africa Mesalazine Sales Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Mesalazine Sales Market Share by Country Table Middle East and Africa Mesalazine Revenue by Country (2014-2019) (Million US$) Table Middle East and Africa Mesalazine Revenue Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Mesalazine Revenue Market Share by Country Figure Turkey Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Turkey Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure GCC Countries Mesalazine Sales Growth Rate (2014-2019) (KG) Figure GCC Countries Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Mesalazine Sales Growth Rate (2014-2019) (KG) Figure Egypt Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Mesalazine Sales Growth Rate (2014-2019) (KG) Figure South Africa Mesalazine Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Mesalazine Sales by Type (2014-2019) (KG) Table Middle East and Africa Mesalazine Sales Market Share by Type (2014-2019) Figure 2018 Middle East and Africa Mesalazine Market Share by Type Table Middle East and Africa Mesalazine Sales by Application (2014-2019) (KG) Table Middle East and Africa Mesalazine Sales Market Share by Application (2014-2019) Figure 2018 Middle East and Africa Mesalazine Market Share by Application Table AstraZeneca Company Details Table AstraZeneca Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table AstraZeneca Recent Development Table Cosmo Pharmaceuticals Company Details Table Cosmo Pharmaceuticals Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Cosmo Pharmaceuticals Recent Development Table Teva Company Details Table Teva Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Teva Recent Development Table Mylan Company Details Table Mylan Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Mylan Recent Development Table Sandoz Mesalamine Company Details Table Sandoz Mesalamine Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Sandoz Mesalamine Recent Development Table Allergan Company Details Table Allergan Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Allergan Recent Development Table Salix Pharmaceuticals Company Details Table Salix Pharmaceuticals Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Salix Pharmaceuticals Recent Development Table Nogra Pharma Company Details Table Nogra Pharma Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Nogra Pharma Recent Development Table Abbvie Company Details Table Abbvie Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Abbvie Recent Development Table Takeda Company Details Table Takeda Mesalazine Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2014-2019) Table Takeda Recent Development Table Janssen (Johnson & Johnson) Company Details Table Pfizer Company Details Table Ferring Company Details Table Boehringer Ingelheim Company Details Table Chiesi Farmaceutici Company Details Table Tillotts Pharma Company Details Table Dr Falk Pharma Company Details Table Cipla Company Details Table Synmosa Biopharma Corporation Company Details Table Lunan Better Pharmaceutical Company Details Table Shanghai Sine Promod Pharmaceutical Company Details Table Global Mesalazine Sales Forecast by Regions 2019-2025 (KG) Table Global Mesalazine Sales Market Share Forecast by Regions 2019-2025 Table Global Mesalazine Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Mesalazine Revenue Market Share Forecast by Regions 2019-2025 Table Global Mesalazine Sales Forecast by Type 2019-2025 (KG) Table Global Mesalazine Sales Market Share Forecast by Type 2019-2025 Table Global Mesalazine Revenue Forecast by Type 2019-2025 (Million US$) Table Global Mesalazine Revenue Market Share Forecast by Type 2019-2025 Table Global Mesalazine Sales Forecast by Application 2019-2025 (KG) Table Global Mesalazine Sales Market Share Forecast by Application 2019-2025 Figure North America Mesalazine Sales Growth Rate Forecast (2019-2025) (KG) Figure North America Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Mesalazine Sales Growth Rate Forecast (2019-2025) (KG) Figure Europe Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Mesalazine Sales Growth Rate Forecast (2019-2025) (KG) Figure Asia Pacific Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Mesalazine Sales Growth Rate Forecast (2019-2025) (KG) Figure Central & South America Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Mesalazine Sales Growth Rate Forecast (2019-2025) (KG) Figure Middle East and Africa Mesalazine Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Key Opportunities and Drivers: Impact Analysis (2019-2025) Table Key Challenges Table Market Risks Figure Porter's Five Forces Analysis Table Mesalazine Value Chain Table Mesalazine Customers List Figure Channels of Distribution Table Mesalazine Distributors List Figure Distributors Profiles Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Key Executives Interviewed Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Get Free Sample

Related Reports

Global Mesalazine Market Insights, Forecast to 2025

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Mesalazine Market Insights, Forecast to 2025

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Mesalazine Market Insights, Forecast to 2025

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Mesalazine Market Insights, Forecast to 2025

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Mesalazine Market Insights, Forecast to 2025

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)